Among these biomarkers are those related to the tumor microenvironment such as tumor infiltrative lymphocytes (TILs) [28] or interferon signaling, CD8 + PD − 1 + Tcells expressing CD28 [65] and gut microbiome in the feces [66]. The gene discussed is RPL17; the disease is neoplasm.